Skip to site menu Skip to page content
Logo Image
In Brief
Spotlight

Thermo Fisher counters tariffs with $2bn investment into US manufacturing

Following in the footsteps of several pharma companies, life sciences giant Thermo Fisher is doubling down on investments at its US sites.

Latest news

Caribou cuts pipeline and workforce to focus on lead CAR-T programmes

Caribou is scaling back its operations, halting multiple programmes, and cutting staff to focus on two cancer programmes.

MSD’s Gardasil sales slide further due to China constraints

MSD is also bracing for a $200m hit due to tariffs as it accelerates US manufacturing and shifts its global supply strategy.

Pharma companies in Europe push for US-level drug prices

Pharma executives emphasise that without urgent action, Europe may face a decline and an acceleration in the departure of companies.

Top 20 biopharmas’ market cap rises 6% in Q1 2025 amid tariff headwinds

The biopharmaceutical industry is positioned for continued recovery, driven by recent FDA approvals and billion-dollar strategic collaborations.

EC grants orphan drug designation to Dyne Therapeutics’ DMD therapy

The company anticipates submitting a biologics licence application for accelerated approval in the US in early 2026.

Granite Bio secures $100m in funding for new antibodies

The financial injection comprises a $30m Series A round and a $70m Series B round.